Angiodynamics (ANGO) EPS (Weighted Average and Diluted) (2010 - 2026)
Angiodynamics (ANGO) reported EPS (Weighted Average and Diluted) of -$0.19 for Q1 2026, down 72.73% on a YoY basis from -$0.7 in Q1 2025, and down 26.67% quarter-over-quarter from -$0.15 in Q4 2025.
Angiodynamics (ANGO) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Angiodynamics has reported EPS (Weighted Average and Diluted) for 17 years, with the latest figure at -$0.19 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 72.73% year-over-year to -$0.19; the trailing twelve-month figure through Feb 2026 stood at -$0.75 (up 25.74% YoY), and the FY2025 full-year result was -$0.83, up 81.92% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.19, down from -$0.15 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $1.15 in Q3 2023, with the low at -$4.67 in Q1 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.45 across 5 years, with a median of -$0.24 in 2023.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) soared 448.48% — and 2024, when it slumped 1845.83%.
- Angiodynamics' EPS (Weighted Average and Diluted) stood at -$0.21 in 2022, then plunged by 242.86% to -$0.72 in 2023, then jumped by 63.89% to -$0.26 in 2024, then surged by 42.31% to -$0.15 in 2025, then decreased by 26.67% to -$0.19 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.19 (Q1 2026), -$0.15 (Q4 2025), and -$0.26 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -0.19 |
| Nov 30, 2025 | -0.15 |
| Aug 31, 2025 | -0.26 |
| May 31, 2025 | -0.15 |
| Feb 28, 2025 | -0.11 |
| Nov 30, 2024 | -0.26 |
| Aug 31, 2024 | -0.31 |
| May 31, 2024 | -0.33 |
| Feb 29, 2024 | -4.67 |
| Nov 30, 2023 | -0.72 |
| Aug 31, 2023 | 1.15 |
| May 31, 2023 | -0.54 |
| Feb 28, 2023 | -0.24 |
| Nov 30, 2022 | -0.21 |
| Aug 31, 2022 | -0.33 |
| May 31, 2022 | -0.16 |
| Feb 28, 2022 | -0.13 |
| Nov 30, 2021 | -0.21 |
| Aug 31, 2021 | -0.18 |
| May 31, 2021 | -0.50 |